Loading...
ALXP
ALTAO
Market cap12mUSD
Oct 28, Last price  
0.01EUR
1D
0.00%
1Q
-1.92%
Jan 2017
-98.76%
IPO
-99.79%
Name

Hybrigenics SA

Chart & performance

D1W1MN
ALXP:ALTAO chart
P/E
—
P/S
17.11
EPS
—
Vol. 1Y
142.69%
Shs. 5Y
—
Rev. 5Y
-34.32%
Div Yld LY
—
Div Yld TTM
—
Revenues
661k
661,000
Net income
-962k
-962,000
CFO
394k
394,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in France, Aton operates as a bioscience enterprise, with its headquarters located in Strasbourg. Established in 1998, the company's extensive operations encompass pharmaceutical research and development, the provision of preclinical and clinical services, and the creation of monoclonal antibodies. Additionally, Aton manufactures laboratory equipment, designs and produces various medical devices—including specialized surgical instruments powered by Stemcis technology—and supplies human tissues.

Key people

Chairman of the Board · since 2015
Guillaume Floch
Chief Financial Officer · since 2008
Etienne Formstecher
Chief Executive Officer of Hybrigenics Services · since 2014
Remi Delansorne
Chief Executive Officer, Director · since 2007
Piet Serrure
Director - representing Rendex NV · since 2008
Albert Saporta
Independent Director · since 2012
IPO date
Dec 17, 2007
Employees
17
Domiciled in
FR
Incorporated in
FR
Headquarters & legal address
850 BOULEVARD SEBASTIEN BRANT
ILLKIRCH-GRAFFENSTADEN 67400
FR
Previous name
HYBRIGENICS SA

Valuation

Title
EUR in thousands, except ratios and share amounts
FY
2025‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT